CNMD
NYSECONMED Corporation
Price$37.47-0.02 (-0.07%)
01:30 PM07:45 PM
News · 26 weeks42-76%
2025-10-262026-04-19
Mix2590d
- Insider16(64%)
- SEC Filings5(20%)
- Earnings2(8%)
- Analyst1(4%)
- Other1(4%)
Latest news
25 items- SECSEC Form DEFA14A filed by CONMED CorporationDEFA14A - CONMED Corp (0000816956) (Filer)
- SECSEC Form DEF 14A filed by CONMED CorporationDEF 14A - CONMED Corp (0000816956) (Filer)
- INSIDERSEC Form 4 filed by Beyer Pat4 - CONMED Corp (0000816956) (Issuer)
- PRCONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic
- SECAmendment: SEC Form SCHEDULE 13G/A filed by CONMED CorporationSCHEDULE 13G/A - CONMED Corp (0000816956) (Subject)
- INSIDERAmendment: SEC Form 4 filed by Lalomia Brent4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Schabacker Matthew4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Foust Hollie K4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Ferrell John D.4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Shagory Peter K4/A - CONMED Corp (0000816956) (Issuer)
- ANALYSTCONMED downgraded by Piper Sandler with a new price targetPiper Sandler downgraded CONMED from Overweight to Neutral and set a new price target of $39.00
- SECCONMED Corporation filed SEC Form 8-K: Leadership Update8-K - CONMED Corp (0000816956) (Filer)
- INSIDERExecutive VP RA, QA Lalomia Brent converted options into 75 shares and covered exercise/tax liability with 26 shares, increasing direct ownership by 6% to 915 units (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by VP GM Advanced Surgical Schabacker Matthew4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by Executive Vice President - HR Ferrell John D.4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by Treasurer and VP, Tax Pelletier Johonna Marie4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by EVP, STRAT & CORP DEVT Shagory Peter K4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by Executive VP RA, QA Lalomia Brent4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by General Counsel & Corp Sec Foust Hollie K4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by VP Corporate Controller Moller Andrew James4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by President & CEO Beyer Pat4 - CONMED Corp (0000816956) (Issuer)
- INSIDERDirector Kaye Mark converted options into 152 shares (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- SECSEC Form 10-K filed by CONMED Corporation10-K - CONMED Corp (0000816956) (Filer)
- SECCONMED Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CONMED Corp (0000816956) (Filer)
- PRCONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial ResultsCONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights Sales of $373.2 million increased 7.9% year-over-year as reported and 7.1% in constant currency. Domestic revenue increased 1.4% year-over-year. International revenue increased 17.0% year-over-year as reported and 15.4% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to diluted net earnings per share (GAAP) of $1.08 in the fourth quarter of 2024. Adjusted diluted net earnings per share(1) were $1.43, compared to adjusted diluted net earnings per share of $1.34 in the fourth quarter of 2